医学
血运重建
心脏病学
内科学
经皮冠状动脉介入治疗
心绞痛
心肌梗塞
不稳定型心绞痛
冠状动脉疾病
作者
Parag H. Joshi,James A. de Lemos
出处
期刊:JAMA
[American Medical Association]
日期:2021-05-04
卷期号:325 (17): 1765-1765
被引量:109
标识
DOI:10.1001/jama.2021.1527
摘要
For patients with stable angina, emphasis should be placed on optimizing lifestyle factors and preventive medications such as lipid-lowering and antiplatelet agents to reduce the risk for cardiovascular events and death. Antianginal medications, such as β-blockers, nitrates, or calcium channel blockers, should be initiated to improve angina symptoms. Revascularization with percutaneous coronary intervention should be reserved for patients in whom angina symptoms negatively influence quality of life, generally after a trial of antianginal medical therapy. Shared decision-making with an informed patient is important for effective treatment of stable angina.
科研通智能强力驱动
Strongly Powered by AbleSci AI